logo

For the Inventor, By the Inventor

Oak Ridge, NC, United States of America

Adnan M M Mjalli

This inventor holds 74 USPTO granted patents and 2 published patent applications and 4 EPO patents, primarily in Pharmaceutical Compositions (CPC class C07D). Top assignees: Transtech Pharma, Inc., Vtv Therapeutics LLC, High Point Pharmaceuticals, LLC. Active years: 2001-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adnan M M Mjalli. Retrieved from https://idiyas.com/inventor/adnan-m-m-mjalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 74 

% Patents Active = 52.7

 

Average Co-Inventor Count = 4.9

ph-index = 14

Forward Citations = 1,183(Granted Patents)

Forward Citations (Not Self Cited) = 1,089(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Jamestown, NC (US) (2001 - 2015)
  • Oak Ridge, NC (US) (2008 - 2023)

Company Filing History:

goldMedal34 out of 49 
 
Transtech Pharma, Inc.
 patents
silverMedal20 out of 54 
 
Vtv Therapeutics LLC
 patents
bronzeMedal11 out of 50 
 
High Point Pharmaceuticals, LLC
 patents
4. 4 out of 1,803 
 
Novo Nordisk A/s
 patents
5. 3 out of 6 
 
Advanced Syntech, LLC
 patents
6. 1 out of 7 
 
Pharmacore, Inc.
 patents
7. 1 out of 834,570 
Other
 patents

Years Active: 2001-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Tricyclic Compounds
Imidazole Derivatives
Glucokinase Activators
Beta-Secretase Inhibitors
Amino Thiazole Derivatives
Oxadiazoanthracene Compounds
Aryl Carbonyl Derivatives
Rage Fusion Proteins
PDE4 Inhibitors
Aurora Kinase Inhibitors
Nucleic Acid Molecules
74 patents (USPTO):Explore Patents
1. 12091407 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2024-09-17),
2. 11649230 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2023-05-16),
3. 11130753 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2021-09-28),
4. 10889580 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2021-01-12),
5. 10570126 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2020-02-25),
6. 10568888 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors (2020-02-25),
7. 10391097 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors (2019-08-27),
8. 10364233 - Piperidine derivative and methods of use thereof (2019-07-30),
9. 10363244 - Compositions comprising metformin and a glucokinase activator (2019-07-30),
10. 10287284 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof (2019-05-14),
11. 10085990 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2018-10-02),
12. 10064846 - Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator (2018-09-04),
13. 9855251 - Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator (2018-01-02),
14. 9833457 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2017-12-05),
15. 9687489 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors (2017-06-27),

Title: The Innovative Journey of Adnan M M Mjalli

Introduction:

Adnan M M Mjalli, a distinguished inventor hailing from Oak Ridge, NC (US), has made significant contributions to the field of innovations and patents through his groundbreaking work.

Latest Patents:

Adnan M M Mjalli holds several patents in various industries, showcasing his versatility and ingenuity in inventing new technologies to solve complex problems.

Career Highlights:

With a career spanning several decades, Adnan M M Mjalli has established himself as a visionary inventor known for his out-of-the-box thinking and ability to transform ideas into tangible inventions that have real-world applications.

Collaborations:

Throughout his career, Adnan M M Mjalli has collaborated with leading research institutions, universities, and companies to further his innovative projects and bring his inventions to the market, solidifying his reputation as a respected figure in the world of patents.

Conclusion:

In conclusion, Adnan M M Mjalli's relentless pursuit of innovation and his passion for creating solutions that make a difference have cemented his legacy as a pioneering inventor whose work continues to inspire future generations in the realm of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…